STRS Ohio’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-200
| Closed | -$260 | – | 2189 |
|
|
2025
Q2 | $260 | Hold |
200
| – | – | ﹤0.01% | 2195 |
|
|
2025
Q1 | $278 | Hold |
200
| – | – | ﹤0.01% | 1922 |
|
|
2024
Q4 | $458 | Hold |
200
| – | – | ﹤0.01% | 1877 |
|
|
2024
Q3 | $544 | Hold |
200
| – | – | ﹤0.01% | 1958 |
|
|
2024
Q2 | $468 | Hold |
200
| – | – | ﹤0.01% | 1947 |
|
|
2024
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 1917 |
|
|
2023
Q4 | $0 | Hold |
200
| – | – | ﹤0.01% | 1907 |
|
|
2023
Q3 | $0 | Hold |
200
| – | – | ﹤0.01% | 1933 |
|
|
2023
Q2 | $1K | Sell |
200
-1,600
| -89% | -$10.7K | ﹤0.01% | 1926 |
|
|
2023
Q1 | $14K | Hold |
1,800
| – | – | ﹤0.01% | 1884 |
|
|
2022
Q4 | $17K | Hold |
1,800
| – | – | ﹤0.01% | 1896 |
|
|
2022
Q3 | $21K | Hold |
1,800
| – | – | ﹤0.01% | 1924 |
|
|
2022
Q2 | $23K | Hold |
1,800
| – | – | ﹤0.01% | 1948 |
|
|
2022
Q1 | $19K | Hold |
1,800
| – | – | ﹤0.01% | 2050 |
|
|
2021
Q4 | $27K | Hold |
1,800
| – | – | ﹤0.01% | 2079 |
|
|
2021
Q3 | $25K | Hold |
1,800
| – | – | ﹤0.01% | 2165 |
|
|
2021
Q2 | $34K | Buy |
+1,800
| New | +$37.2K | ﹤0.01% | 2147 |
|
STRS Ohio's AKYA Position: Q3 2025 in Review
STRS Ohio sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 200 shares — an estimated $260 sold.
STRS Ohio first reported a position in AKYA in Q2 2021 and held it in 17 quarters. The position peaked at $34K in Q2 2021. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- STRS Ohio reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- STRS Ohio sold 200 Akoya BioSciences shares in Q3 2025, an estimated $260.
- STRS Ohio first reported a position in Akoya BioSciences in Q2 2021 and held it in 17 quarters.
- STRS Ohio's Akoya BioSciences position peaked at $34K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on STRS Ohio's 13F filing for Q3 2025, filed 30 Oct 2025.